CompanyGraph
Sign in
Medical Distribution

Medical Distribution

Extremely thin distribution margins measured in low single-digit percentages require massive throughput volume, while regulatory chain-of-custody requirements impose compliance costs across every handling step.

Medical distribution serves as the logistical intermediary that receives products from pharmaceutical manufacturers and medical device companies, consolidates them into climate-controlled warehousing, and delivers them to healthcare providers on schedules ranging from next-day to multiple times daily. The core transformation is inventory consolidation: rather than each healthcare provider maintaining direct purchasing relationships with every manufacturer, the distributor aggregates demand and supply into an efficient intermediary layer spanning thousands of SKUs.

The economics are characterized by high revenue and very thin margins. Distributor compensation comes through buy-side margins, manufacturer fees for service, and prompt-pay discounts, with branded pharmaceutical margins often below two percent of product cost. Profitability depends on volume throughput, working capital efficiency, and ancillary service revenue. Regulatory requirements for product tracing, controlled substance handling, cold chain maintenance, and storage conditions impose substantial operational overhead that scales with product breadth.

As a midstream logistics layer, medical distribution connects upstream manufacturers to downstream healthcare delivery points. The structural divide between high-volume commodity distribution and high-touch specialty logistics for biologics, oncology drugs, and rare disease therapies reflects differing capability requirements: the former demands automation and route optimization, while the latter requires patient support programs, reimbursement assistance, and clinical data management.

Structural Role

Operates the logistics and inventory infrastructure that moves pharmaceutical products, medical devices, and supplies from manufacturers to healthcare delivery points, consolidating thousands of product lines into reliable distribution systems that bridge manufacturing and patient care.

Scale Differentiation

Large distributors operate national warehouse networks with automated picking systems, serving hospital systems and pharmacy chains through high-frequency deliveries, and leveraging volume for manufacturer agreements and technology investment. Mid-size distributors serve regional markets or specialize in specific product categories such as specialty pharmaceuticals. Smaller distributors fill niches in underserved geographies or product segments where delivery frequency and personalized service outweigh national scale cost advantages.

Constraint Archetype

Throughput-Bound Conversion

A regime where the rate at which physical inputs can be converted into outputs through fixed-capacity plant defines the economic ceiling.

Financial Profile

Measured across the 30 companies in this industry with recorded financial statements. Each band spans the middle 90% of companies — 5th to 95th percentile — with the mark at the median. How wide a band runs is itself a reading: a tight band means the industry imposes its economics on every member; a wide one means outcomes differ sharply between its strongest and weakest companies.

Profitability

Gross margin10.7%median
3.6%40.5%
Operating margin3.4%median
0
-3.0%8.4%
Net margin1.9%median
0
-3.8%8.3%

Returns & efficiency

Return on equity7.6%median
0
-4.3%22.5%
Asset turnover1.22×median
0.38×4.19×
Free cash flow / revenue0.8%median
0
-11.0%9.9%

Balance sheet

Current ratio1.38×median
0.87×1.97×
Debt to equity0.40×median
0.02×1.81×

Reinvestment & payout

R&D / revenue0.4%median
0.0%3.1%
Capex / revenue0.9%median
0.2%3.8%

What marks this industry

Where this industry’s typical company sits against the typical company in every other industry we measure — metric by metric.

Gross margin
10.7%typical industry 29.4%

2nd lowest of 101 industries with this measure.

Operating margin
3.4%typical industry 8.1%

4th lowest of 101 industries with this measure.

Capex / revenue
0.9%typical industry 3.8%

6th lowest of 101 industries with this measure.

Net margin
1.9%typical industry 5.4%

6th lowest of 101 industries with this measure.

Scale

28
companies with recorded market value
$2.1B
median company · global median $1.2B
$419M – $60.1B
middle 90% of companies
$293.8B
combined market value

The largest member carries roughly 35% of the combined market value; half the companies sit under $2.1B.

Valuation ranges

Price to book1.03×median
0.40×5.44×
Price to earnings21.08×median
6.61×68.46×
EV / EBITDA13.05×median
0.04×35.35×

Bands are 5th–95th percentiles across this industry’s companies, computed from reported financial statements. Ratios are currency-free; money values are USD-normalized. These distributions describe how the industry is shaped — they are not a rating of it, and a company’s position inside them is not a forecast. Benchmark set computed 18 September 2026.

Connected Industries

Drug Manufacturers General

Distributes for

Distributes branded pharmaceuticals

Drug Manufacturers Specialty & Generic

Distributes for

Medical Care Facilities

Distributes for

Delivers pharmaceuticals and supplies to hospitals and clinics

Medical Devices

Distributes for

Pharmaceutical Retailers

Distributes for

Supplies retail pharmacies

Trucking

Provides infrastructure for

Temperature-controlled delivery logistics

Stocks